Net profit of Shukra Pharmaceuticals declined 88.54% to Rs 0.54 crore in the quarter ended September 2024 as against Rs 4.71 crore during the previous quarter ended September 2023. Sales declined 77.44% to Rs 5.56 crore in the quarter ended September 2024 as against Rs 24.64 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales5.5624.64 -77 OPM %12.0520.62 - PBDT1.585.26 -70 PBT0.884.70 -81 NP0.544.71 -89 Powered by Capital Market - Live News

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 September 2024.Powered by Capital Market - Live News

Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Net profit of Shukra Pharmaceuticals rose 16.67% to Rs 0.49 crore in the quarter ended June 2024 as against Rs 0.42 crore during the previous quarter ended June 2023. Sales declined 84.23% to Rs 3.18 crore in the quarter ended June 2024 as against Rs 20.16 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales3.1820.16 -84 OPM %25.791.69 - PBDT1.480.89 66 PBT0.810.43 88 NP0.490.42 17 Powered by Capital Market - Live News